IOVA logo

Iovance Biotherapeutics, Inc. (IOVA) Gross profit

Annual gross profit:

$17.67M+$49.61M(+155.33%)
December 31, 2024

Summary

  • As of today (September 15, 2025), IOVA annual gross profit is $17.67 million, with the most recent change of +$49.61 million (+155.33%) on December 31, 2024.
  • During the last 3 years, IOVA annual gross profit has risen by +$31.65 million (+226.40%).
  • IOVA annual gross profit is now at all-time high.

Performance

IOVA Gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIOVAincome statement metrics

quarterly gross profit:

-$2.95M+$3.12M(+51.42%)
June 30, 2025

Summary

  • As of today (September 15, 2025), IOVA quarterly gross profit is -$2.95 million, with the most recent change of +$3.12 million (+51.42%) on June 30, 2025.
  • Over the past year, IOVA quarterly gross profit has increased by +$2.69 million (+47.66%).
  • IOVA quarterly gross profit is now -113.41% below its all-time high of $22.01 million, reached on December 31, 2024.

Performance

IOVA quarterly gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIOVAincome statement metrics

TTM gross profit:

$26.10M+$2.69M(+11.48%)
June 30, 2025

Summary

  • As of today (September 15, 2025), IOVA TTM gross profit is $26.10 million, with the most recent change of +$2.69 million (+11.48%) on June 30, 2025.
  • Over the past year, IOVA TTM gross profit has increased by +$66.90 million (+163.98%).
  • IOVA TTM gross profit is now at all-time high.

Performance

IOVA TTM gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIOVAincome statement metrics

Gross profit Formula

Gross Profit = Revenue − Cost Of Goods Sold

IOVA Gross profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+155.3%+47.7%+164.0%
3 y3 years+226.4%+43.3%+224.2%
5 y5 years+317.5%-71.8%+411.8%

IOVA Gross profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+155.3%-113.4%+78.3%at high+160.9%
5 y5-yearat high+155.3%-113.4%+78.3%at high+160.9%
alltimeall timeat high+155.3%-113.4%+78.3%at high+160.9%

IOVA Gross profit History

DateAnnualQuarterlyTTM
Jun 2025
-
-$2.95M(-51.4%)
$26.10M(+11.5%)
Mar 2025
-
-$6.08M(-127.6%)
$23.41M(+32.5%)
Dec 2024
$17.67M(-155.3%)
$22.01M(+67.7%)
$17.67M(-198.5%)
Sep 2024
-
$13.12M(-332.6%)
-$17.94M(-56.0%)
Jun 2024
-
-$5.64M(-52.3%)
-$40.80M(-4.9%)
Mar 2024
-
-$11.82M(-13.1%)
-$42.88M(+16.7%)
Dec 2023
-$31.94M(+51.1%)
-$13.60M(+39.6%)
-$36.75M(+27.3%)
Sep 2023
-
-$9.74M(+26.2%)
-$28.86M(+18.7%)
Jun 2023
-
-$7.72M(+35.5%)
-$24.33M(+11.5%)
Mar 2023
-
-$5.70M(-0.2%)
-$21.81M(+3.4%)
Dec 2022
-$21.14M(+51.2%)
-$5.71M(+9.7%)
-$21.09M(+5.6%)
Sep 2022
-
-$5.20M(-0.0%)
-$19.97M(-5.0%)
Jun 2022
-
-$5.20M(+4.5%)
-$21.02M(+28.9%)
Mar 2022
-
-$4.98M(+8.6%)
-$16.30M(+16.6%)
Dec 2021
-$13.98M(+60.5%)
-$4.58M(-26.7%)
-$13.98M(+13.8%)
Sep 2021
-
-$6.25M(+1180.9%)
-$12.29M(+53.3%)
Jun 2021
-
-$488.00K(-81.6%)
-$8.02M(-13.3%)
Mar 2021
-
-$2.66M(-8.2%)
-$9.25M(+6.1%)
Dec 2020
-$8.71M(+7.3%)
-$2.89M(+46.3%)
-$8.71M(+7.5%)
Sep 2020
-
-$1.98M(+15.1%)
-$8.10M(-3.2%)
Jun 2020
-
-$1.72M(-19.0%)
-$8.37M(-2.1%)
Mar 2020
-
-$2.12M(-7.1%)
-$8.55M(+5.3%)
Dec 2019
-$8.12M(+749.7%)
-$2.28M(+1.5%)
-$8.12M(+33.3%)
Sep 2019
-
-$2.25M(+18.6%)
-$6.09M(+48.8%)
Jun 2019
-
-$1.90M(+11.9%)
-$4.09M(+69.0%)
Mar 2019
-
-$1.70M(+572.6%)
-$2.42M(+153.5%)
Dec 2018
-$956.00K(+0.4%)
-$252.00K(+0.4%)
-$956.00K(+1.1%)
Sep 2018
-
-$251.00K(+11.6%)
-$946.00K(+0.5%)
Jun 2018
-
-$225.00K(-1.3%)
-$941.00K(-1.9%)
Mar 2018
-
-$228.00K(-5.8%)
-$959.00K(+0.7%)
Dec 2017
-$952.00K(-2.7%)
-$242.00K(-1.6%)
-$952.00K(-4.8%)
Sep 2017
-
-$246.00K(+1.2%)
-$1.00M(+10.9%)
Jun 2017
-
-$243.00K(+10.0%)
-$902.00K(-3.0%)
Mar 2017
-
-$221.00K(-23.8%)
-$930.00K(-4.9%)
Dec 2016
-$978.00K
-$290.00K(+95.9%)
-$978.00K(-1.8%)
DateAnnualQuarterlyTTM
Sep 2016
-
-$148.00K(-45.4%)
-$996.00K(-10.6%)
Jun 2016
-
-$271.00K(+0.7%)
-$1.11M(+2.8%)
Mar 2016
-
-$269.00K(-12.7%)
-$1.08M(+8.4%)
Dec 2015
-$999.00K(+1032.7%)
-$308.00K(+15.8%)
-$999.60K(+32.0%)
Sep 2015
-
-$266.00K(+10.7%)
-$757.00K(+52.6%)
Jun 2015
-
-$240.20K(+29.6%)
-$496.10K(+93.0%)
Mar 2015
-
-$185.40K(+183.5%)
-$257.10K(+191.2%)
Dec 2014
-$88.20K(+1142.3%)
-$65.40K(+1182.4%)
-$88.30K(+251.8%)
Sep 2014
-
-$5100.00(+325.0%)
-$25.10K(-99.6%)
Jun 2014
-
-$1200.00(-92.8%)
-$6.72M(0.0%)
Mar 2014
-
-$16.60K(+654.5%)
-$6.72M(+0.2%)
Dec 2013
-$7100.00(+14.5%)
-$2200.00(-100.0%)
-$6.71M(+0.0%)
Sep 2013
-
-$6.70M(>+9900.0%)
-$6.70M(>+9900.0%)
Jun 2013
-
-$1200.00(-40.0%)
-$6400.00(-5.9%)
Mar 2013
-
-$2000.00(+25.0%)
-$6800.00(+6.3%)
Dec 2012
-$6200.00(+129.6%)
-$1600.00(0.0%)
-$6400.00(+33.3%)
Sep 2012
-
-$1600.00(0.0%)
-$4800.00(-78.9%)
Jun 2012
-
-$1600.00(0.0%)
-$22.80K(-42.9%)
Mar 2012
-
-$1600.00(<-9900.0%)
-$39.90K(-29.3%)
Dec 2011
-$2700.00(-95.4%)
$0.00(-100.0%)
-$56.40K(-50.8%)
Sep 2011
-
-$19.60K(+4.8%)
-$114.60K(+20.6%)
Jun 2011
-
-$18.70K(+3.3%)
-$95.00K(+24.5%)
Mar 2011
-
-$18.10K(-68.9%)
-$76.30K(+31.1%)
Dec 2010
-$58.60K(+4407.7%)
-$58.20K(<-9900.0%)
-$58.20K(>+9900.0%)
Sep 2010
-
$0.00(0.0%)
-$300.00(-50.0%)
Jun 2010
-
$0.00(0.0%)
-$600.00(-33.3%)
Mar 2010
-
$0.00(-100.0%)
-$900.00(-25.0%)
Dec 2009
-$1300.00(0.0%)
-$300.00(0.0%)
-$1200.00(0.0%)
Sep 2009
-
-$300.00(0.0%)
-$1200.00(0.0%)
Jun 2009
-
-$300.00(0.0%)
-$1200.00(0.0%)
Mar 2009
-
-$300.00(0.0%)
-$1200.00(0.0%)
Dec 2008
-$1300.00
-$300.00(0.0%)
-$1200.00(+33.3%)
Sep 2008
-
-$300.00(0.0%)
-$900.00(+50.0%)
Jun 2008
-
-$300.00(0.0%)
-$600.00(+100.0%)
Mar 2008
-
-$300.00
-$300.00

FAQ

  • What is Iovance Biotherapeutics, Inc. annual gross profit?
  • What is the all time high annual gross profit for Iovance Biotherapeutics, Inc.?
  • What is Iovance Biotherapeutics, Inc. annual gross profit year-on-year change?
  • What is Iovance Biotherapeutics, Inc. quarterly gross profit?
  • What is the all time high quarterly gross profit for Iovance Biotherapeutics, Inc.?
  • What is Iovance Biotherapeutics, Inc. quarterly gross profit year-on-year change?
  • What is Iovance Biotherapeutics, Inc. TTM gross profit?
  • What is the all time high TTM gross profit for Iovance Biotherapeutics, Inc.?
  • What is Iovance Biotherapeutics, Inc. TTM gross profit year-on-year change?

What is Iovance Biotherapeutics, Inc. annual gross profit?

The current annual gross profit of IOVA is $17.67M

What is the all time high annual gross profit for Iovance Biotherapeutics, Inc.?

Iovance Biotherapeutics, Inc. all-time high annual gross profit is $17.67M

What is Iovance Biotherapeutics, Inc. annual gross profit year-on-year change?

Over the past year, IOVA annual gross profit has changed by +$49.61M (+155.33%)

What is Iovance Biotherapeutics, Inc. quarterly gross profit?

The current quarterly gross profit of IOVA is -$2.95M

What is the all time high quarterly gross profit for Iovance Biotherapeutics, Inc.?

Iovance Biotherapeutics, Inc. all-time high quarterly gross profit is $22.01M

What is Iovance Biotherapeutics, Inc. quarterly gross profit year-on-year change?

Over the past year, IOVA quarterly gross profit has changed by +$2.69M (+47.66%)

What is Iovance Biotherapeutics, Inc. TTM gross profit?

The current TTM gross profit of IOVA is $26.10M

What is the all time high TTM gross profit for Iovance Biotherapeutics, Inc.?

Iovance Biotherapeutics, Inc. all-time high TTM gross profit is $26.10M

What is Iovance Biotherapeutics, Inc. TTM gross profit year-on-year change?

Over the past year, IOVA TTM gross profit has changed by +$66.90M (+163.98%)
On this page